"Weild & Co., led by Mr. David Weild, brings tremendous experience in the capital markets, and specifically understands newly-created mechanisms under the JOBS Act that allow for Alternate Reporting companies such as Amarantus to gain access to pools of capital that were previously unreachable for us," said Gerald E. Commissiong, President & CEO of Amarantus.
The problem is that we are no longer an "Alternate Reporting company." Thought we were going the Reg A+ route?
(2)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links